Erratum: Intrinsic B cell hypo-responsiveness in mice prematurely expressing human CR2/CD21 during B cell development (European Journal of Immunology (2007) vol. 37 (3) 10.1002/eji.200636248);Intrinsic B cell hypo-responsiveness in mice prematurely expressing human CR2/CD21 during B cell development

European Journal of Immunology

Volumn 37, Issue 3, 2007, Pages 623-633

  Kulik, Liudmila ^a   Marchbank, Kevin J ^b   Lyubchenko, Taras ^a   Kuhn, Kristine A ^a   Liubchenko, Ganna A ^a   Haluszczak, Catherine ^a   Gibson, Matthew G ^a   Boackle, Susan A ^a   Holers, V Michael ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

B lymphocytes; Cellular differentiation; Complement; Rodent; Transgenic

Indexed keywords

B LYMPHOCYTE RECEPTOR; CALCIUM ION; COLLAGEN; COMPLEMENT COMPONENT C3D RECEPTOR; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; LEUKOSIALIN; T LYMPHOCYTE ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; B LYMPHOCYTE; BONE DISEASE; CALCIUM TRANSPORT; CHONDROPATHY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEVELOPMENTAL STAGE; DISEASE MODEL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTOPOIESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROLYMPHOCYTE; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; SYNOVITIS; T LYMPHOCYTE; TRANSGENIC MOUSE; WILD TYPE; ANIMAL; ANTIBODY PRODUCTION; BIOSYNTHESIS; C57BL MOUSE; CELL DIFFERENTIATION; CYTOLOGY; DBA MOUSE; GENETICS; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALE; METABOLISM; PHYSIOLOGY;

ANIMALS; ANTIBODY FORMATION; ARTHRITIS, EXPERIMENTAL; B-LYMPHOCYTES; CELL DIFFERENTIATION; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, B-CELL; RECEPTORS, COMPLEMENT 3D; SIGNAL TRANSDUCTION;

EID: 34147156635     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200790009     Document Type: Erratum

References (27)

1. Prodinger, W. M., Complement receptor type two (CR2, CR21): A target for influencing the humoral immune response and antigen-trapping. Immunol. Res. 1999. 20: 187-194.
2. Nielsen, C. H., Fischer, E. M. and Leslie, R. G., The role of complement in the acquired immune response. Immunology 2000. 100: 4-12.
3. Prechl, J. and Erdei, A., Immunomodulatory functions of murine CR1/2. Immunopharmacology 2000. 49: 117-124.
4. Carroll, M. C., CD21/CD3S in B cell activation. Semin. Immunol. 1998. 10: 279-286.
5. Fearon, D. T. and Carroll, M. C., Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annu. Rev. Immunol. 2000. 18: 393-422.
6. Poe, J. C., Hasegawa, M. and Tedder, T. F., CD19, CD21, and CD22: multifaceted response regulators of B lymphocyte signal transduction. Int. Rev. Immunol. 2001. 20: 739-762.
7. Fearon, D. T. and Carter, R. H., The CD19/CR2/TAPA-1 complex of B lymphocytes: Linking natural to acquired immunity. Annu. Rev. Immunol. 1995. 13: 127-149.
8. Tedder, T. F., Zhou, L. J. and Engel, P., The CD19/CD21 signal transduction complex of B lymphocytes. Immunol. Today 1994. 15: 437-442.
9. Tedder, T. F., Haas, K. M. and Poe, J. C., CD19-CD21 complex regulates an intrinsic Src family kinase amplification loop that links innate immunity with B-lymphocyte intracellular calcium responses. Biochem. Soc. Trans. 2002. 30: 807-811.
10. Molina, H., Kinoshita, T., Inoue, K., Carel, J. C. and Holers, V. M., A molecular and immunochemical characterization of mouse CR2. Evidence for a single gene model of mouse complement receptors 1 and 2. J. Immunol. 1990. 145: 2974-2983.
11. Kurtz, C. B., O'Toole, E., Christensen, S. M. and Weis, J. H., The murine complement receptor gene family. IV. Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1. J. Immunol. 1990. 144: 3581-3591.
12. Fingeroth, J. D., Comparative structure and evolution of murine CR2. The homolog of the human C3d/EBV receptor (CD21). J. Immunol. 1990. 144: 3458-3467.
13. Molina, H., Kinoshita, T., Webster, C. B. and Holers, V. M., Analysis of C3b/C3d binding sites and factor I cofactor regions within mouse complement receptors 1 and 2. J. Immunol. 1994. 153: 789-795.
14. Molina, H., Holers, V. M., Li, B., Fung, Y., Mariathasan, S., Goellner, J., Strauss-Schoenberger, J. et al., Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc. Natl. Acad. Sci. USA 1996. 93: 3357-3361.
15. Ahearn, J. M., Fischer, M. B., Croix, D., Goerg, S., Ma, M., Xia, J., Zhou, X. et al., Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity 1996. 4: 251-262.
16. Marchbank, K. J., Kulik, L., Gipson, M. G., Morgan, B. P. and Holers, V. M., Expression of human complement receptor type 2 (CD21) in mice during early B cell development results in a reduction in mature B cells and hypogammaglobulinemia. J. Immunol. 2002. 169: 3526-3535.
17. Marchbank, K. J., Watson, C. C., Ritsema, D. F. and Holers, V. M., Expression of human complement receptor 2 (CR2, CD21) in Cr2-/- mice restores humoral immune function. J. Immunol. 2000. 165: 2354-2361.
18. Birrell, L., Kulik, L., Morgan, B. P., Holers, V. M. and Marchbank, K. J., B cells from mice prematurely expressing human complement receptor type 2 are unresponsive to T-dependent antigens. J. Immunol. 2005. 174: 6974-6982.
19. Henson, S. E., Smith, D., Boackle, S. A., Holers, V. M. and Karp, D. R., Generation of recombinant human C3dg tetramers for the analysis of CD21 binding and function. J. Immunol. Methods 2001. 258: 97-109.
20. Lyubchenko, T., dal Porto, J., Cambier, J. C. and Holers, V. M., Coligation of the B cell receptor with complement receptor type 2 (CR2/ CD21) using its natural ligand C3dg: Activation without engagement of an inhibitory signaling pathway. J. Immunol. 2005. 174: 3264-3272.
21. Guthridge, J. M., Young, K., Gipson, M. G., Sarrias, M. R., Szakonyi, G., Chen, X. S., Malaspina, A. et al., Epitope mapping using the X-ray crystallographic structure of complement receptor type 2 (CR2)/ CD21: Identification of a highly inhibitory monoclonal antibody that directly recognizes the CR2-C3d interface. J. Immunol. 2001. 167: 5758-5766.
22. Del Nagro, C. J., Kolla, R. V. and Rickert, R. C., A critical role for complement C3d and the B cell coreceptor (CD19/CD21) complex in the initiation of inflammatory arthritis. J. Immunol. 2005. 175: 5379-5389.
23. Noorchashm, H., Bui, A., Li, H. L., Eaton, A., Mandik-Nayak, L., Sokol, C., Potts, K. M. et al., Characterization of anergic anti-DNA B cells: B cell anergy is a T cell-independent and potentially reversible process. Int. Immunol. 1999. 11: 765-776.
24. Acevedo-Suarez, C. A., Hulbert, C., Woodward, E. J. and Thomas, J. W., Uncoupling of anergy from developmental arrest in anti-insulin B cells supports the development of autommume diabetes. J. Immunol. 2005. 174: 827-833.
25. Dempsey, P. W., Allison, M. E., Akkaraju, S., Goodnow, C. C. and Fearon, D. T., C3d of complement as a molecular adjuvant: Bridging innate and acquired immunity. Science 1996. 271: 348-350.
26. Chakravarty, L., Zabel, M. D., Weis, J. J. and Weis, J. H., Depletion of Lyn kinase from the BCR complex and inhibition of B cell activation by excess CD21 ligation. Int. Immunol. 2002. 14: 139-146.
27. Banda, N. K., Kraus, D., Vondracek, A., Huynh, L. H., Bendele, A., Holers, V. M. and Arend, W. P., Mechanisms of effects of complement inhibition in murine collagen-induced arthritis. Arthritis Rheum. 2002. 46: 3065-3075.